For over three decades, CEI has advocated health care reforms that put more power in the hands of consumers to choose their health providers, treatment protocols, and scope of insurance coverage. We have advocated reform of the Food and Drug Administration’s drug and device approval process to allow for greater flexibility and patient choice. And in 2013, CEI organized the court challenges to Obamacare’s exchange subsidies that concluded with the Supreme Court’s King v. Burwell decision.
Healthcare Issue Areas
Featured Posts
National Review
The Return of the Cadillac Tax?
Like the phoenix, a key piece of the Affordable Care Act has risen from the ashes, resurrected, believe it or not, by the Republican Study Committee…
Blog
Free the Economy podcast: Paying for organs with Pete Jaworski
In this week’s episode we cover the future of AI and employment, why we shouldn’t trust Chinese economic statistics, and how the…
City Journal
A Solution in Search of a Problem
In his State of the Union address, President Biden touted the drug-price controls in his Inflation Reduction Act (IRA). Though the price controls have yet…
Search Posts
Op-Eds
Much Ado About Nothing?
The last year has been a bad one for future AIDS victims. The U.N. AIDS conference in Barcelona was an activist circus. U.S. Secretary…
News Release
Senate Vote a Setback for Public Health
<?xml:namespace prefix = st1 ns = “urn:schemas-microsoft-com:office:smarttags” />Washington, D.C., July 24, 2003—The U.S. Senate yesterday approved a measure that would allow the Food…
Op-Eds
West Nile Virus: A Public Health Crisis?
Full article available in pdf format Public health officials can only hope that this summer doesn't see a repeat of last year's…
Roll Call
Fireworks Fly
Op-Eds
Recent Research Suggests…
There has been a great deal of ballyhoo this week over the decision by the U.S. Food and Drug Administration to require food products…
News Release
Pharmaceutical Re-Imports Threaten Medical Innovation
Contact for Interviews: Richard Morrison, 202.331.2273 Washington, D.C., July 18, 2003—The Competitive Enterprise Institute is opposing proposals to allow the re-importation of drugs from foreign…